What is Arima Genomics?
Arima Genomics is at the forefront of life sciences innovation, specializing in 3D genomics. The company provides advanced technologies that offer unparalleled access to the sequence and structure of any genome. By preserving and presenting the structural organization of the genome, Arima Genomics empowers researchers to drive discovery in genome biology and human health. Their solutions are critical for understanding complex genetic interactions and developing novel therapeutic strategies.
How much funding has Arima Genomics raised?
Arima Genomics has raised a total of $7.8M across 3 funding rounds:
Debt
$350K
Debt
$411K
Series B
$7M
Debt (2020): $350K with participation from PPP
Debt (2021): $411K led by PPP
Series B (2022): $7M supported by GENETRON HEALTH, Ladder Ventures, Tech Coast Angels, Agile Technologies, and Hiaqua Investments
Key Investors in Arima Genomics
GENETRON HEALTH
Genetron Health is a leading precision oncology platform company in China, specializing in cancer molecular profiling and harnessing advanced technologies in molecular biology and data science to transform cancer treatment. They offer a comprehensive oncology portfolio covering the entire spectrum of cancer management.
Agile Technologies
Agile Technologies is a technology service firm dedicated to building long-term relationships that deliver powerful business results through technology, business processes, and communications. They focus on creating value for clients.
Tech Coast Angels
Tech Coast Angels is a prominent angel investment group known for backing early-stage technology companies. They provide capital and strategic guidance to promising startups.
What's next for Arima Genomics?
The recent major strategic investment positions Arima Genomics for significant expansion and further technological development. This capital infusion is expected to fuel advancements in their 3D genomics platforms, potentially leading to new product offerings and broader market penetration. The company is likely to focus on scaling its operations, enhancing its research and development capabilities, and forging new partnerships within the biotechnology and pharmaceutical sectors. Arima Genomics' trajectory suggests a strong future in enabling breakthroughs in personalized medicine and disease research.
See full Arima Genomics company page
